Peptide questions, checked carefully.Independent peptide information · Sources on every review · No sales · No dosing.

Claim being checked · Version 1 · Reviewed

“The randomized Forzinity study clearly improved walking and fatigue.”

Written and source-checked by Anthony Treviso, founder of The Peptide Field.

No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.

Misleading. This statement leaves out a limit that changes its meaning.

Answer scope

This verdict checks the exact claim in the heading. It is not a universal grade for SS-31.

01 · Answer

Misleading

FDA says the randomized study did not show superiority to placebo on its initial walking and fatigue measures. The approval used a knee-extensor muscle-strength measure and later extension data.

What kind of evidence this is
Randomized human outcomes. This answer uses a study that assigned people to groups by chance and measured a health outcome.
What this answer covers
The randomized Barth syndrome study and its defined measures; this does not establish a result for other diseases or products. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
Question type
Clinical outcomes. What a study measured about people's health, symptoms, or ability to function.

02 · Sources

Read the sources behind this answer

Editorial review
Internal editorial review recorded
Source review
Anthony Treviso · Founder and responsible editor
Medical review status
Not independently medically reviewed. Editorial source review does not replace medical review.